Taking Drug Dosing Off Autopilot Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life. by Marcus A. Banks Reasons to Hope During the COVID-19 Pandemic Patient advocates learned about COVID-19 and cancer in an AACR virtual forum. by Kevin McLaughlin From the Editor-in-Chief Cancer in Minority Populations Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all. by William G. Nelson, MD, PhD Survivor Profile An Unlikely Pivot Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers. by Lindsey Konkel In It for the Long Haul Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward. by Kate Yandell Q&A Taking the Long View In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy. by Marci A. Landsmann Parking Costs Take a Hidden Toll on Cancer Patients People with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds. by Marcus A. Banks Survivor Profile Sharing Her Strength Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer. by Lindsey Konkel A Modern Family My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent. by Allison Rosen Cancer Care Moves Forward Amid COVID-19 Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care. by Kate Yandell next Cancer Talk Cancer Centers Cope With COVID-19 Surge Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge. by Ashley P. Taylor Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky More Posts